Pharma-backed TransCelerate makes progress on clinical trial efficiency

TransCelerate BioPharma, the non-profit organization founded by 10 big pharma companies to quickly address issues that hamper clinical trial efficiency, has taken swift action on all five of the objectives the group outlined in 2012 when it was first established. In addition, the group has adopted a list of five new priorities.

TransCelerate BioPharma, the non-profit organization founded by 10 big pharma companies to quickly address issues that hamper clinical trial efficiency, has taken swift action on all five of the objectives the group outlined in 2012 when it was first established. In addition, the group has adopted a list of five new priorities.

"As some projects become part of company practices, we then take on new ones," TransCelerate CEO Dalvir Gill told Scrip...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet